(주)모아바이오

Minerva Biolabs

[Minerva Biolabs] Mynox® Gold

Cat-No. 10-0201

Minerva Biolabs는 세포배양 및 바이오의약품에서의 mycoplasma, bacteria, virus를 검출/오염방지/제거 등을

컨트롤할 수 있는 고품질의 다양한 키트와 제품을 제공하는 독일 소재의 제조사입니다.

제품 설명

Mynox® Gold

제품 번호

10-0201 / size: 2 treatments

10-0501 / 5 treatments

10-1001 / 10 treatments

제품 특징

Mynox® Gold is a further development of the classic Mynox®. Mynox® Gold is a combination of a standard antibiotic ciprofloxacin with the biological Mynox® reagent surfactin. One application includes an initial treatment that eliminates most mycoplasmas without affecting the cells. The follow-up treatments destroy the remaining mycoplasmas. The mode of action of Mynox® Gold is based on a biophysical mechanism to integrate into the membrane of mycoplasmas and thereby impair their integrity.

Benefits

Functionality test
Technical Note on the functional testing of Mynox® Gold. Removal of mycoplasma from a Vero cell line contaminated with mycoplasma.
Low resistance risk
The combination of the standard antibiotic ciprofloxacin and the Mynox® reagent surfactin virtually eliminates the possibility of resistance to Mynox® Gold when eliminating mycoplasmas.
Highly effective
The eradication efficiency is close to 100 %.
Mycoplasma removal from virus stocks
Protocol for the pre-treatment of virus stocks available as a Technical Note.

Recommended Use

Mynox® Gold is intended for research use only and not for clinical applications. Not applicable for the direct treatment of cells that serve as host cells for Chlamydia or other bacterial host cells. The level of antibiotics in the product may affect the integrity of the parasites.

Content

One application of Mynox® Gold contains one vial for the starter treatment and three vials for the main treatment. Each vial contains 500 µl as a sterile, ready-to-use solution.